Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma
Abstract Purpose The present is conducted with the aim of comparing the clinical efficacy and side effects of oral versus intralesional propranolol treatment of infantile capillary hemangiomas. Methods Study enrolled 40 infants diagnosed with infantile capillary hemangiomas. Patients were divided in...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-07-01
|
| Series: | Egyptian Pediatric Association Gazette |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43054-025-00371-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849335329914355712 |
|---|---|
| author | Sahar S Sheta Kareem B. Elessawy Nadeen Eltoukhy Ayman Esmail Walaa ElNaggar |
| author_facet | Sahar S Sheta Kareem B. Elessawy Nadeen Eltoukhy Ayman Esmail Walaa ElNaggar |
| author_sort | Sahar S Sheta |
| collection | DOAJ |
| description | Abstract Purpose The present is conducted with the aim of comparing the clinical efficacy and side effects of oral versus intralesional propranolol treatment of infantile capillary hemangiomas. Methods Study enrolled 40 infants diagnosed with infantile capillary hemangiomas. Patients were divided into two groups: Group A (non-invasive group) included 20 infants who received oral propranolol hydrochloride starting with the 1 mg/kg/day BID dose, then rose to a max of 2 mg/kg/day BID gradually over 2 weeks for three months. Group B (invasive group) included 20 infants, who received intralesional propranolol injection at a dose of 1 mg/mL. The size of the lesion served as the factor that determined the volume of drug injection (0.2 mL injection/cm of the diameter of the lesion), considering the use of 1 mL for a 5-cm diameter lesion as a maximum case under complete aseptic conditions in the operating theater. Results At 3 months after initiating treatment, the circumferential size of the hemangioma showed a statistically significant decrease in both groups; in group A from 3.66 ± 2.89 cm to 1.56 ± 1.26 cm with P-value < 0.05 and in group B from 2.99 ± 2.73 cm to 1.32 ± 1.18 cm with P-value < 0.05. There is no statistically significant comparative difference between the two groups (P-value = 0.538 = insignificant). Regarding the complications of oral propranolol, one patient(5%) had bradycardia, and one patient (5%) had diarrhea. In the injection group, 20 patients (100%) had local edema, and 1 patient (5%) experienced local infection. Conclusions Both oral non-invasive and intralesional invasive propranolol are safely and equally statistically successfully effective in the treatment of infantile hemangioma, showing reduction of the size of the hemangioma with no statistical comparative difference between both treatment techniques. |
| format | Article |
| id | doaj-art-fb98e2ba5a0d4bdf81654682d6efb9ad |
| institution | Kabale University |
| issn | 2090-9942 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Egyptian Pediatric Association Gazette |
| spelling | doaj-art-fb98e2ba5a0d4bdf81654682d6efb9ad2025-08-20T03:45:19ZengSpringerOpenEgyptian Pediatric Association Gazette2090-99422025-07-017311810.1186/s43054-025-00371-wComparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangiomaSahar S Sheta0Kareem B. Elessawy1Nadeen Eltoukhy2Ayman Esmail3Walaa ElNaggar4Cairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityAbstract Purpose The present is conducted with the aim of comparing the clinical efficacy and side effects of oral versus intralesional propranolol treatment of infantile capillary hemangiomas. Methods Study enrolled 40 infants diagnosed with infantile capillary hemangiomas. Patients were divided into two groups: Group A (non-invasive group) included 20 infants who received oral propranolol hydrochloride starting with the 1 mg/kg/day BID dose, then rose to a max of 2 mg/kg/day BID gradually over 2 weeks for three months. Group B (invasive group) included 20 infants, who received intralesional propranolol injection at a dose of 1 mg/mL. The size of the lesion served as the factor that determined the volume of drug injection (0.2 mL injection/cm of the diameter of the lesion), considering the use of 1 mL for a 5-cm diameter lesion as a maximum case under complete aseptic conditions in the operating theater. Results At 3 months after initiating treatment, the circumferential size of the hemangioma showed a statistically significant decrease in both groups; in group A from 3.66 ± 2.89 cm to 1.56 ± 1.26 cm with P-value < 0.05 and in group B from 2.99 ± 2.73 cm to 1.32 ± 1.18 cm with P-value < 0.05. There is no statistically significant comparative difference between the two groups (P-value = 0.538 = insignificant). Regarding the complications of oral propranolol, one patient(5%) had bradycardia, and one patient (5%) had diarrhea. In the injection group, 20 patients (100%) had local edema, and 1 patient (5%) experienced local infection. Conclusions Both oral non-invasive and intralesional invasive propranolol are safely and equally statistically successfully effective in the treatment of infantile hemangioma, showing reduction of the size of the hemangioma with no statistical comparative difference between both treatment techniques.https://doi.org/10.1186/s43054-025-00371-wHemangiomaOral beta blockerIntralesional beta blocker |
| spellingShingle | Sahar S Sheta Kareem B. Elessawy Nadeen Eltoukhy Ayman Esmail Walaa ElNaggar Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma Egyptian Pediatric Association Gazette Hemangioma Oral beta blocker Intralesional beta blocker |
| title | Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma |
| title_full | Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma |
| title_fullStr | Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma |
| title_full_unstemmed | Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma |
| title_short | Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma |
| title_sort | comparative study between oral and intralesional injection of beta blocker in the treatment of infantile capillary hemangioma |
| topic | Hemangioma Oral beta blocker Intralesional beta blocker |
| url | https://doi.org/10.1186/s43054-025-00371-w |
| work_keys_str_mv | AT saharssheta comparativestudybetweenoralandintralesionalinjectionofbetablockerinthetreatmentofinfantilecapillaryhemangioma AT kareembelessawy comparativestudybetweenoralandintralesionalinjectionofbetablockerinthetreatmentofinfantilecapillaryhemangioma AT nadeeneltoukhy comparativestudybetweenoralandintralesionalinjectionofbetablockerinthetreatmentofinfantilecapillaryhemangioma AT aymanesmail comparativestudybetweenoralandintralesionalinjectionofbetablockerinthetreatmentofinfantilecapillaryhemangioma AT walaaelnaggar comparativestudybetweenoralandintralesionalinjectionofbetablockerinthetreatmentofinfantilecapillaryhemangioma |